Agfa HealthCare and Barco Team Up on Program to Upgrade Diagnostic Displays

Agfa HealthCareAgfa HealthCare announces the launch of a new joint program with Barco to refresh the diagnostic display systems that are running IMPAX PACS (picture archiving and communication systems) solutions. The 'display refresh program' will provide customers with access to the latest diagnostic display technology, to meet the demands of new trends in healthcare IT.

Diagnostic displays for evolving PACS
As PACS evolve, so does the technology used in diagnostic displays. Agfa HealthCare is committed to enabling its customers to take full advantage of advances and new applications. "Currently, most diagnostic imaging is still done on conventional monochrome Liquid Crystal Display (LCD) displays. But with the explosive growth in image data, new ways to present the images must be found," explains Al Dyer, Imaging Informatics Global Business Manager for Agfa HealthCare. "This means more advanced image presentation techniques, including, for example, an increased use of color. To make sure our customers get the most from our PACS solutions, we want to support them in transitioning to the latest display technology."

"Diagnostic color displays allow customers to use Agfa HealthCare's color-enabled PACS features and advanced visualization capabilities. Furthermore, they offer the flexibility and efficiency radiologists need to streamline their workflow and accelerate their clinical performance." The color displays also allow the reading of grayscale images, offering the same level of grayscale image quality as the traditional displays.

Maximizing the clinical performance of the PACS system
In addition to enabling customers to make optimal use of the advanced PACS features and visualization applications, such as registration and fusion, nuclear medicine, cardiology and volume viewing, the program will support the optimal clinical performance of the healthcare enterprise's PACS system, as customers will have access to a secure, online, enterprise-wide Quality Assurance service. Finally, the LCD upgrade opportunity in the program provides customers with both the latest technology and accelerated performance.

"We are pleased that this program will enable us to better serve our existing customers," comments Al Dyer. "Thanks to the embedded Quality Assurance service, our customers will enjoy higher system uptime and greater diagnostic confidence, while freeing up valuable IT resources."

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...